Frankfurt - Delayed Quote EUR

Cellectar Biosciences, Inc. (NV4.F)

Compare
0.2160
+0.0160
+(8.00%)
As of 8:16:34 AM GMT+1. Market Open.
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
12,075.5800
21,589.7900
37,201.8090
58,659.3700
Total Liabilities Net Minority Interest
27,234.5480
13,436.5460
4,156.6550
3,864.8410
Total Equity Gross Minority Interest
-15,158.9680
8,153.2440
33,045.1540
54,794.5290
Total Capitalization
-15,158.9680
8,153.2440
33,045.1540
54,794.5290
Preferred Stock Equity
4,677.6320
1,382.0230
1,382.0230
20,035.8490
Common Stock Equity
-19,836.6000
8,153.2440
31,663.1310
34,758.6800
Capital Lease Obligations
552.9820
603.8280
301.7410
421.6440
Net Tangible Assets
-15,158.9680
8,153.2440
33,045.1540
54,794.5290
Working Capital
-14,905.3090
9,028.0590
32,581.0970
54,376.7080
Invested Capital
-19,836.6000
8,153.2440
31,663.1310
34,758.6800
Tangible Book Value
-19,836.6000
8,153.2440
31,663.1310
34,758.6800
Total Debt
552.9820
603.8280
301.7410
421.6440
Share Issued
20,744.1100
9,385.2720
6,110.1260
4,544.2720
Ordinary Shares Number
20,744.1100
9,385.2720
6,110.1260
4,544.2720
Preferred Shares Number
--
0.2040
--
--
12/31/2020 - 12/8/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers